View on web

THE TOP NEWS IN MARIJUANA LAW REFORM

Volume 26   •   Issue 35   •   August 31, 2023

Researchers concluded: “Within six weeks on the therapy, median pain scores decreased significantly. There were no severe adverse events reported.”

“Sublingual CBD was found to be well-tolerated and provided statistically significant improvements in several BPS parameters,” investigators determined.

Report: Leaked HHS Letter Calls Upon DEA to Reschedule Cannabis  8/30/23

I’m Interning at NORML to Become a Stronger Advocate for Justice  8/29/23

Analysis: Many ‘Hemp-Derived’ Delta-9 THC Products Sold Over the Counter Contain Synthetically Derived THC  8/25/23

"Participants reported more energy and vitality [and] also better mental and general health status.”

FEDERAL: Tell Your Senators to Support the SAFE Banking Act

FEDERAL: Tell Congress to Prioritize Cannabis Policy Reform in 2023

FEDERAL: Support the Veterans Equal Access Act

FEDERAL: Support Medical Cannabis Research and Access for Veterans

Despite the lack of impairment, subjects still tested positive for trace levels of THC — potentially putting them at risk of violating certain traffic safety laws.

FEDERAL: Rescheduling cannabis is not enough, NORML says

NORML COMMENTARY IN THE WASHINGTON POST: “Light a fire under the feds on marijuana reform”

LEARN: Cannabis smoke exposure doesn’t pose the same health risks as tobacco smoke

VIRGINIA: NORML pushes back against supposed ‘marijuana-laced fentanyl’ claims

READ: NORML’s Deputy Director in The Boston Globe “Congress is stunting state-approved cannabis industry’s growth”

NORML's mission is supported by thousands of people across America as we work to reform marijuana laws in all 50 states and at the federal level.

Can you chip in $5 today to help us keep up the fight?